Kyralizer Syrup is a pharmaceutical formulation containing Citric Acid (334 mg/5 ml) and Potassium Citrate (1100 mg/5 ml), indicated primarily for the management of urinary tract conditions associated with metabolic acidosis and renal calculi. The combination of citric acid and potassium citrate acts as an alkalinizing agent, helping to increase urinary pH and citrate concentration, thereby reducing the formation of calcium-containing kidney stones and promoting their dissolution. Citric acid serves as a precursor to bicarbonate in the body, aiding in systemic acid-base balance, while potassium citrate provides potassium ions essential for maintaining electrolyte homeostasis. Kyralizer Syrup is commonly prescribed in conditions such as renal tubular acidosis, gout, and certain types of kidney stones where urine alkalinization is beneficial. The syrup formulation allows for ease of administration, particularly in pediatric and geriatric populations. Dosage should be individualized based on patient condition, renal function, and response to therapy, with careful monitoring of serum potassium levels to avoid hyperkalemia. Adverse effects are generally mild but may include gastrointestinal discomfort or electrolyte imbalance if not properly managed. Kyralizer Syrup should be used under medical supervision, especially in patients with impaired renal function or those on potassium-sparing medications.